Cystic Fibrosis News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

FDA Approves Symdeko to Treat the Underlying Cause of Cystic Fibrosis - AJMC.com Managed Markets Network



The Pharma Letter
 
FDA Approves Symdeko to Treat the Underlying Cause of Cystic Fibrosis 
AJMC.com Managed Markets Network
Drug maker Vertex has announced that the FDA has approved tezacaftor/ivacaftor and ivacaftor (Symdeko) for the treatment of the underlying cause of cystic fibrosis (CF) in patients aged 12 or older who have 2 copies of the F508del mutation in the ...
Look back at pharma news in week to Feb 16 The Pharma Letter

all 2 news articles » 


King attends world record snowmobile ride for Cystic Fibrosis - Daily Bulldog



Daily Bulldog
 
King attends world record snowmobile ride for Cystic Fibrosis 
Daily Bulldog
OQUOSSOC ? U.S. Senator Angus King (I-Maine) attended the World Record Snowmobile Ride for Cystic Fibrosis at Bald Mountain Camps in the Rangeley Lakes region recently. Senator King participated in a snowmobile ride and provided remarks. The snowmobile ...

and more » 


Santhera, reeling from DMD blow, lands cystic fibrosis drug ... - FierceBiotech



FierceBiotech
 
Santhera, reeling from DMD blow, lands cystic fibrosis drug ... 
FierceBiotech
Santhera Pharmaceuticals has licensed a clinical-phase cystic fibrosis asset from Polyphor. The Swiss biotech penned a CHF 127.5 million ($138 million) deal for the human neutrophil elastase inhibitor to expand its clinical pipeline.
Santhera Obtains Worldwide Exclusive License from Polyphor to ... GlobeNewswire (press release)
Santhera Obtains Worldwide Exclusive License from Polyphor to Develop and Commercialize Clinical Stage ... Nasdaq

all 4 news articles » 


FDA approves another Vertex drug for treatment of cystic fibrosis - The Boston Globe



The Boston Globe
 
FDA approves another Vertex drug for treatment of cystic fibrosis 
The Boston Globe
The Food and Drug Administration on Monday approved a treatment for cystic fibrosis that combines Vertex Pharmaceuticals Inc's Kalydeco with another medicine, Vertex said, marking the company's third product for the life-shortening lung disorder ...
U.S. FDA approves Vertex cystic fibrosis combination treatment Reuters
Vertex scores FDA approval for new cystic fibrosis drug Boston Business Journal
US FDA approves Vertex cystic fibrosis combination treatment Nasdaq
Business Wire (press release)  -Xconomy  -Chicago Evening Post 
all 5 news articles » 


A Student With Cystic Fibrosis Explains How Her Wheelchair Is A Fashion Statement - TeenVogue.com



TeenVogue.com
 
A Student With Cystic Fibrosis Explains How Her Wheelchair Is A Fashion Statement 
TeenVogue.com
The 20-year-old Harvard student has Cystic Fibrosis which is a terminal illness that mostly affects the respiratory and gastrointestinal system. Due to complications from her disease, she often has to use a wheelchair to get around. As a fashion lover ...

 


FDA Clears Tezacaftor/Ivacaftor Combo for Cystic Fibrosis - Medscape



Medscape
 
FDA Clears Tezacaftor/Ivacaftor Combo for Cystic Fibrosis 
Medscape
"We've already seen the significant impact that disease-modifying medicines can have on patients and are incredibly pleased that there is now a third treatment option that enables more patients to benefit from CFTR modulation," Patrick Flume, MD ...
FDA Approves New Cystic Fibrosis Drug Combo MedPage Today
FDA OKs Combo Treatment for Cystic Fibrosis Caused by Certain Mutations Pharmacy Times
FDA Approves Combination Therapy for Cystic Fibrosis Rare Disease Report
Investor's Business Daily  -Monthly Prescribing Reference  -Zacks.com 
all 24 news articles » 


Blyth mum backs cystic fibrosis 'wonder drug' Orkambi which she hopes can help young son - ChronicleLive



ChronicleLive
 
Blyth mum backs cystic fibrosis 'wonder drug' Orkambi which she hopes can help young son 
ChronicleLive
A Blyth mum has welcomed the news that Parliament is to debate a petition calling for cystic fibrosis sufferers to be given access to a ?wonder drug? on the NHS. Experts believe the Orkambi drug could prevent the disease from becoming severe later in ...
Cystic fibrosis petition spearheaded by Hull sufferer to be discussed in parliament Hull Daily Mail

all 2 news articles » 


Vertex Picks 'Impressive' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market - Forbes



Forbes
 
Vertex Picks 'Impressive' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market 
Forbes
Vertex Pharmaceuticals has picked two cystic fibrosis drugs to test in combination with its existing CF medicine, Kalydeco, as part of two different three-drug combinations aimed at helping as many as 90% of patients with cystic fibrosis. (Vertex's ...
Vertex chooses two drugs to advance in cystic fibrosis triple ... CNBC
Vertex advances drugs with potential to reach far more with cystic ... STAT
Vertex picks cystic fibrosis triple combos for Phase III trials Reuters
FierceBiotech  -Boston Business Journal  -Investor's Business Daily 
all 15 news articles » 


Perth couple with cystic fibrosis face their toughest fight yet - 9Honey



9Honey
 
Perth couple with cystic fibrosis face their toughest fight yet 
9Honey
Not every couple can say they met one another before they could even talk. Then again, Kaila and Matt Maartensz are not every couple. The Perth locals were ?practically babies? when they encountered one another for the first time at a children's ...

 


How Proteostasis' Recent Data In Cystic Fibrosis Compares To Vertex's - Seeking Alpha



How Proteostasis' Recent Data In Cystic Fibrosis Compares To Vertex's 
Seeking Alpha
Cystic Fibrosis (CF) is a progressive, inherited disease that causes complications in the vital organs of the body. It is caused by a mutation in the CFTR protein which causes a thickening of bodily fluids including sweat, digestive fluid, and mucus ...